MarketsStocksALIVUS
AL

Alivus Life Sciences Ltd

NSE: ALIVUSBSE: 543322Healthcare
1,037.90
-0.02%
NSE · 15-min delayed
Prev Close
₹1,023.50
Day High
₹1,064.40
Day Low
₹1,031.40
Mkt Cap
₹2,591 Cr
P / E
22.9
P / B
0.8
ROE
16.9%
52W High
₹1,148.40
52W Low
₹819.00
Key Metrics
Market Cap
₹2,591 Cr
P / E
22.9
P / B
0.8
ROCE
22.7%
ROE
16.9%
Div Yield
0.5%
Revenue · ₹ Cr
2.1k
FY22
2.2k
FY23
2.3k
FY24
2.4k
FY25
2.6k
FY26
Net Profit · ₹ Cr
419
FY22
467
FY23
471
FY24
486
FY25
564
FY26
EPS · ₹ per share
₹35.6
FY22
₹38.1
FY23
₹38.4
FY24
₹39.6
FY25
₹46.0
FY26
P / E Ratio · price ÷ TTM EPS
8182838173350Mar 22Aug 23Jan 25Jun 26
P/E 22.5×Median 20.6×TTM EPS
Q1 2026 snapshot
Sales
₹712 Cr
Operating profit
-
OPM
-
Net profit
₹163 Cr
EPS
₹13.23
Scorecard · 7 axes
Quality
Strong
75/100
Valuation
Good
22.9×
Growth
Avg
+6.2%
Profitability
Good
19.8%
Performance
Weak
+2.6%
Entry Point
Weak
90%
Red Flags
Strong
0 flags
Shareholding Pattern
74.9%Promoter
Promoter74.9%
FII5.3%
DII7.3%
Public12.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue641.844659.63610.83602.7686.82711.89
Net Profit136.96141.868121.535130.026150.261162.661
NPM %21.3%21.5%19.9%21.6%21.9%22.8%
AlertPre-trade